ChiCTR2500099566 版本V1.0 版本创建时间2025/03/25 17:52:42 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500099566 

最近更新日期:

Date of Last Refreshed on:

2025-03-25 17:52:30 

注册时间:

Date of Registration:

2025-03-25 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

犬尿氨酸代谢产物在儿童青少年抑郁症转相预测的观察研究

Public title:

An observational study of kynurenine metabolites in the phase-to-phase prediction of depression in children and adolescents

注册题目简写:

English Acronym:

研究课题的正式科学名称:

犬尿氨酸代谢产物在儿童青少年抑郁症转相预测的观察研究

Scientific title:

An observational study of kynurenine metabolites in the phase-to-phase prediction of depression in children and adolescents

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

云雅君 

研究负责人:

云雅君 

Applicant:

YunYajun 

Study leader:

YunYajun 

申请注册联系人电话:

Applicant telephone:

+86 15879114042

研究负责人电话:

Study leader's telephone:

+86 10 83024225

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yunyj2021@163.com

研究负责人电子邮件:

Study leader's E-mail:

yunyj2021@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国北京市昌平区黄土南店7号

研究负责人通讯地址:

中国北京市昌平区黄土南店7号

Applicant address:

No 7, HuangtuNandian, ChangPing District, Beijing, China

Study leader's address:

No 7, HuangtuNandian, ChangPing District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京回龙观医院

Applicant's institution:

Beijing HuiLongGuan Hospital

研究负责人所在单位:

北京回龙观医院

Affiliation of the Leader:

Beijing HuiLongGuan Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-21-科

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京回龙观医院伦理委员会

Name of the ethic committee:

Ethics Committee of Beijing Huilongguan Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-01-24 00:00:00

伦理委员会联系人:

孙延囡

Contact Name of the ethic committee:

Sun YanNan

伦理委员会联系地址:

中国北京市昌平区黄土南店7号

Contact Address of the ethic committee:

No 7, HuangtuNandian, ChangPing District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 83024461

伦理委员会联系人邮箱:

Contact email of the ethic committee:

ynsun2011@163.com

研究实施负责(组长)单位:

北京回龙观医院

Primary sponsor:

Beijing HuiLongGuan Hospital

研究实施负责(组长)单位地址:

中国北京市昌平区黄土南店7号

Primary sponsor's address:

No 7, HuangtuNandian, ChangPing District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京回龙观医院

具体地址:

中国北京市昌平区黄土南店7号

Institution
hospital:

Beijing HuiLongGuan Hospital

Address:

No 7, HuangtuNandian, ChangPing District, Beijing, China

经费或物资来源:

财政

Source(s) of funding:

Government Funding

Target disease:

Major depressive disorder

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

通过队列研究和文献回顾,旨在筛选出与儿童和青少年期抑郁症患者转变为双相情感障碍相关的犬尿氨酸代谢产物因素,并建立相关的预测模型。  

Objectives of Study:

Through a cohort study and literature review, this research aims to identify kynurenine metabolism-related factors associated with the transition from depression to bipolar disorder in children and adolescents, and to develop a predictive model.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合DSM-5抑郁症的诊断标准;
2.汉密尔顿抑郁量表-l7项总分≥8分;
3.年龄6~18岁;
4.患者及监护人自愿参与研究,并签知情同意书。

Inclusion criteria

1.Meets the diagnostic criteria for depression according to DSM-5; 2.Hamilton Depression Rating Scale-17 total score >= 8; 3.Aged 6 to 18 years; 4.The patient and their guardian voluntarily participate in the study and sign the informed consent form.

排除标准:

1.可能影响中枢神经系统和免疫功能的重大内科疾病或药物使用;
2.过去6个月内的物质依赖或目前的物质滥用(尼古丁除外);
3.既往或目前共病其他精神疾病。

Exclusion criteria:

1.Major medical conditions or medication use that may affect the central nervous system and immune function;
2.Substance dependence within the past 6 months or current substance abuse (excluding nicotine);
3.A history of or current comorbid psychiatric disorders.

研究实施时间:

Study execute time:

From 2025-04-01 00:00:00 To 2027-10-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-04-01 00:00:00 To 2027-10-31 00:00:00  

干预措施:

Interventions:

组别:

抑郁症组

样本量:

98

Group:

MDD

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China 

Province:

Beijing 

City:

 

单位(医院):

北京回龙观医院 

单位级别:

三级甲等 

Institution
hospital:

Beijing HuiLongGuan Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

色氨酸代谢产物(色氨酸/犬尿氨酸/犬尿酸/喹啉酸/3-羟基犬尿氨酸/5-羟色胺)

指标类型:

主要指标

Outcome:

Tryptophan metabolites (tryptophan / kynurenine / kynureic acid / quinoline acid / 3-hydroxykynurenine / serotonin)

Type:

Primary indicator

测量时间点:

基线、1月、6月、12月、24月

测量方法:

高效液相色谱串联质谱法检测

Measure time point of outcome:

Baseline,1 month,6 months,12 months,24 months

Measure method:

HPLC-MS/MS

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 6 years
最大 Max age 18 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

对数据收集工具进行培训,确保操作人员能够正确、统一地收集数据。定期进行数据质量审核和验证,及时发现并纠正数据错误。确保数据安全存储,选择使用加密存储、备份存档等方式。确保数据的机密性和隐私性,符合相关法律法规和伦理标准。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Train data collection personnel to ensure they can collect data correctly and consistently. Conduct regular data quality audits and validation to promptly identify and correct data errors. Ensure data is securely stored, using methods such as encrypted storage and backup archiving. Maintain data confidentiality and privacy, ensuring compliance with relevant laws, regulations, and ethical standards.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-03-25 17:52:30